Advertisement

A Potential Cytosolic Function of Bestrophin-1

  • Olaf Strauß
  • Rudgar Neussert
  • Claudia Müller
  • Vladimir M. Milenkovic
Conference paper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 723)

Abstract

Mutations in the BEST1 gene lead to a variety of retinal degenerations. In the eye, the BEST1 gene product bestrophin-1 is expressed in the retinal pigment epithelium (RPE). It is likely that retinal degenerations are caused by a change of the RPE function. Recent publications indicated that endogenously expressed bestrophin-1 function as a cytosolic Cl channel in Ca2+ stores of the endoplasmic reticulum influences intracellular Ca2+ signaling. Possible cytosolic function of BEST1 could help to understand discrepancies between the bestrophin-1 function in overexpression systems and in animal models as well as to develop new ways to understand BEST1-associated retinal degenerations.

Keywords

VMD2 BEST1 Ca2+-signaling Ca2+ stores Endoplasmic reticulum Vitelliform macular dystrophy Best disease Endogenously expressed bestrophin-1 

References

  1. Arden GB and Constable PA (2006) The electro-oculogram. Prog Retin Eye Res 25: 207–248PubMedCrossRefGoogle Scholar
  2. Barro-Soria R, Aldeni F, Almaca J et al (2010) ER-localized bestrophin 1 activates Ca2+-dependent ion channels TMEM16A and SK4 possibly by acting as a counterion channel. Pflugers Arch 459: 485–497PubMedCrossRefGoogle Scholar
  3. Barro-Soria R, Spitzner M, Schreiber R et al (2009) Bestrophin-1 enables Ca2+-activated Cl- conductance in epithelia. J Biol Chem 284: 29405–29412PubMedCrossRefGoogle Scholar
  4. Boon CJ, Klevering BJ, Leroy BP et al (2009) The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog Retin Eye Res 28: 187–205PubMedCrossRefGoogle Scholar
  5. Brandman O, Liou M, Park WS et al (2007) STIM2 is a feedback regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+ levels. Cell 131: 1327–1339PubMedCrossRefGoogle Scholar
  6. Burgess R, Millar ID, Leroy BP et al (2008) Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet 82: 19–31PubMedCrossRefGoogle Scholar
  7. Hartzell HC, Qu Z, Yu K et al (2008) Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies. Physiol Rev 88: 639–672PubMedCrossRefGoogle Scholar
  8. Jentsch TJ, Stein V, Weinreich F et al (2002) Molecular structure and physiological function of chloride channels. Physiol Rev 82: 503–568PubMedGoogle Scholar
  9. Marmorstein AD, Marmorstein LY, Rayborn M et al (2000) Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci USA 97: 12758–12763PubMedCrossRefGoogle Scholar
  10. Marmorstein LY, Wu J, McLaughlin P et al (2006) The light peak of the electroretinogram is dependent on voltage-gated calcium channels and antagonized by bestrophin (best-1). J Gen Physiol 127: 577–589PubMedCrossRefGoogle Scholar
  11. Marquardt A, Stohr H, Passmore LA et al (1998) Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best’s disease). Hum Mol Genet 7: 1517–1525PubMedCrossRefGoogle Scholar
  12. Milenkovic VM, Soria RB, Aldehni F et al (2009) Functional assembly and purinergic activation of bestrophins. Pflugers Arch 458: 431–441PubMedCrossRefGoogle Scholar
  13. Mullins RF, Oh KT, Heffron E et al (2005) Late development of vitelliform lesions and flecks in a patient with best disease: clinicopathologic correlation. Arch Ophthalmol 123: 1588–1594PubMedCrossRefGoogle Scholar
  14. Neussert R, Muller C, Milenkovic VM et al (2010) The presence of bestrophin-1 modulates the Ca2+ recruitment from Ca2+ stores in the ER. Pflugers Arch 460: 163–175PubMedCrossRefGoogle Scholar
  15. Peachey NS, Stanton JB, Marmorstein (2002) Noninvasive recording and response characteristics of the rat DC-electroretinogram. Vis Neurosci 19: 693–701PubMedCrossRefGoogle Scholar
  16. Petrukhin K, Koisti MJ, Bakall B et al (1998) Identification of the gene responsible for Best macular dystrophy. Nat Genet 19: 241–247PubMedCrossRefGoogle Scholar
  17. Putney JW Jr (2005) Capacitative calcium entry: sensing the calcium stores. J Cell Biol 169: 381–382PubMedCrossRefGoogle Scholar
  18. Reichhart N, Milenkovic VM, Halsband CA et al (2010) Effect of bestrophin-1 on L-type Ca2+ channel activity depends on the Ca2+ channel beta-subunit. Exp Eye Res 91: 630–639PubMedCrossRefGoogle Scholar
  19. Rosenthal R, Bakall B, Kinnick T et al (2006) Expression of bestrophin-1, the product of the VMD2 gene, modulates voltage-dependent Ca2+ channels in retinal pigment epithelial cells. Faseb J 20: 178–180PubMedGoogle Scholar
  20. Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85: 845–881PubMedCrossRefGoogle Scholar
  21. Sun H, Tsunenari T, Yau KW et al (2002) The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci USA 99: 4008–4013PubMedCrossRefGoogle Scholar
  22. Tsunenari T, Sun H, Williams J et al (2003) Structure-function analysis of the bestrophin family of anion channels. J Biol Chem 278: 41114–41125PubMedCrossRefGoogle Scholar
  23. Yu K, Cui Y, Hartzell HC (2006) The bestrophin mutation A243V, linked to adult-onset vitelliform macular dystrophy, impairs its chloride channel function. Invest Ophthalmol Vis Sci 47: 4956–4961PubMedCrossRefGoogle Scholar
  24. Yu K, Xiao Q, Cui G et al (2008) The best disease-linked Cl- channel hBest1 regulates Ca V 1 (L-type) Ca2+ channels via src-homology-binding domains. J Neurosci 28: 5660–5670PubMedCrossRefGoogle Scholar
  25. Zhang Y, Stanton JB, Wu J et al (2010) Suppression of Ca2+ signaling in a mouse model of Best disease. Hum Mol Genet 19: 1108–1118PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  • Olaf Strauß
    • 1
  • Rudgar Neussert
    • 2
  • Claudia Müller
    • 1
  • Vladimir M. Milenkovic
    • 1
  1. 1.Experimental Ophthalmology, Eye HospitalUniversity Health Center RegensburgRegensburgGermany
  2. 2.Experimental Ophthalmology, Eye HospitalUniversity Hospital Hamburg-EppendorfHamburgGermany

Personalised recommendations